Scarica l'app Stockscreener
0.4572
3.45%
0.0028
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché XAIR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.46
Aprire:
$0.475
Volume 24 ore:
59,417
Relative Volume:
0.21
Capitalizzazione di mercato:
$5.71M
Reddito:
$6.92M
Utile/perdita netta:
$-32.03M
Rapporto P/E:
-0.0844
EPS:
-5.4201
Flusso di cassa netto:
$-22.13M
1 W Prestazione:
+18.67%
1M Prestazione:
-7.42%
6M Prestazione:
-60.01%
1 anno Prestazione:
+160.90%
Intervallo 1D:
$0.4501
$0.4759
Intervallo di 1 settimana:
$0.3938
$0.49
Portata 52W:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Nome
Beyond Air Inc
Settore
Industria
Telefono
516-665-8200
Indirizzo
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.4501 | 5.84M | 6.92M | -32.03M | -22.13M | -5.4201 |
ABT
Abbott Laboratories
|
86.53 | 149.10B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
303.26 | 116.96B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
74.38 | 94.76B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.29 | 71.81B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.80 | 49.79B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-17 | Iniziato | D. Boral Capital | Buy |
| 2024-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-07-28 | Iniziato | Piper Sandler | Overweight |
| 2023-06-15 | Iniziato | BTIG Research | Buy |
| 2021-04-28 | Iniziato | Truist | Buy |
| 2019-10-22 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Beyond Air Inc Borsa (XAIR) Ultime notizie
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing - The Manila Times
Beyond Air granted extension to regain Nasdaq compliance By Investing.com - Investing.com Canada
Nasdaq gives Beyond Air until July 31 to meet bid-price rule - Stock Titan
Beyond Air Inc. (XAIR) Hovers Near Support as Selling Pressure Eases SlightlyDonchian Channel - Newser
Beyond Air Inc. (XAIR) Q1 2026 Earnings: Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline AdvancesEBITDA Estimate Trend - Newser
Beyond Air Inc. (XAIR) Q1 2026 Earnings: Narrowing Losses but Revenue Remains AbsentAnalyst Drop Coverage - Newser
Beyond Air Inc. (XAIR) Holds Near Flatline as Stock Tests Key Support ZonePullback Trade - Newser
Beyond Air (XAIR) Q1 2026 Earnings: EPS $-0.83 Beats EstimatesSocial Buy Zones - newser.com
XAIR Technical Analysis | Trend, Signals & Chart Patterns | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Alyeska (XAIR) files 13G/A — reports zero beneficial ownership (amendment) - Stock Titan
Balyasny Group (NASDAQ: XAIR) reports 7.25% position in Beyond Air - Stock Titan
XAIR Stock Price, Quote & Chart | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
TradingKey - TradingKey
Lucid, Beyond Air, Conagra stocks hit 52-week lows: What's behind the drag? - MSN
XAIR (Beyond Air) shares tumble 12% despite 220% revenue surge, puzzling analysts on earnings day.Expansion Phase - newser.com
Beyond Air | DEF 14A: Definitive information statements - Moomoo
XAIR (Beyond Air) matches Q1 2026 analyst EPS estimates, shares fall 1.79 percent on muted investor sentiment. - Newser
D. Boral Capital Maintains Beyond Air (XAIR) Buy Recommendation - MSN
Beyond Air Q2 2026 Earnings Preview - MSN
Beyond Air (NASDAQ: XAIR) seeks approval for 1-for-2 to 1-for-20 reverse split to address $1 bid rule - Stock Titan
Beyond Air registers 719,561 shares for potential resale by warrant holders - MSN
XAIR (Beyond Air) Q1 2026 revenue surges 219.7 percent year over year, shares jump 4.68 percent.Debt Analysis Report - newsline.com
Beyond Air (XAIR) Market Position | Q1 2026: Profit SurprisesOpen Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Beyond Air (XAIR) Stock: Trend Strength (Touches High) 2026-04-20Hot Community Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Beyond Air (XAIR) Reports Promising Data from Phase 1 Clinical T - GuruFocus
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 - The Manila Times
After UNO tumor injection, 6 of 10 heavily treated patients remain alive - Stock Titan
Beyond Air | 8-K: Current report - Moomoo
Lucid, Beyond Air, and Conagra Shares Hit New Lows Amid Weak Guidance - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
XAIR (Beyond Air Inc.) reports 219.7 percent year over year Q1 revenue growth, but shares drop 11.71 percent today.Analyst Drop Coverage - newsline.com
Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag? - Stocktwits
Beyond Air Appeals Nasdaq Notice on Listing Compliance - TipRanks
Beyond Air (NASDAQ: XAIR) appeals Nasdaq $1 bid-price noncompliance in May hearing - Stock Titan
Beyond Air to Participate in the D. Boral Capital Global Conference 2026 - The Manila Times
Trend Review: Can Beyond Air Inc deliver consistent EPS growth2026 Reactions & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Beyond Air Inc Azioni (XAIR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.19%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):